weight-loss Articles | Developments Today

How the 'holy grail' weight loss pill became a reality, and what comes next

GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment

After years of development challenges, oral GLP-1 weight loss drugs are finally hitting the market. Novo Nordisk's oral Wegovy is already available, with Eli Lilly's orforglipron expected to win FDA approval soon.

Key Takeaways

Novo Nordisk's oral Wegovy is now available, with Lilly's orforglipron approval expected soon
Creating oral GLP-1 drugs required solving major absorption challenges with peptide molecules
The pill format could dramatically expand the $50 billion+ GLP-1 market to new patient populations

DE

DT Editorial AI·Mar 8, 2026·via statnews.com

close up of weight-loss injector pens on a conveyer belt (via scientificamerican.com)

Health

The Next Shot: How GLP-1 Research Is Rewriting the Future of Weight Loss Medicine

With one in eight American adults now taking GLP-1 medications like Ozempic and Wegovy, researchers at Georgia State University have uncovered why patients regain weight after stopping treatment — and a potential combination therapy that could solve the problem by targeting the brain's stress response system.

Key Takeaways

One in eight U.S. adults now takes GLP-1 medications like Ozempic or Wegovy for weight management
GLP-1 drugs activate the brain's stress response system, elevating cortisol and causing muscle loss
Patients who stop treatment experience rebound overeating driven by chronically stimulated stress hormones
Combination therapy with anti-CRH antibodies preserved muscle and maintained weight loss after drug discontinuation
Human clinical trials of the combination approach are being planned pending partnership development

DE

DT Editorial AI·Feb 17, 2026·via medicalxpress.com

Health

NTU Scientists Develop Gut-Based Compound That Blocks Fat Absorption Safely

An oral compound from NTU Singapore reduces intestinal fat uptake and promotes beneficial gut bacteria without toxic side effects in animal models.

Key Takeaways

NTU researchers develop an oral gut-based compound that blocks fat absorption without entering systemic circulation
The compound works by blocking intestinal fat receptors and promoting beneficial gut bacteria that produce short-chain fatty acids
Animal models showed less weight gain on high-fat diets, with a commercialization path starting as a supplement

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

Diagram showing the composition and distribution of intestinal microflora

Health

Natural Gut Compound Shows Promise for Safe Weight Loss

Researchers identify a naturally occurring gut molecule that reduces appetite and promotes fat burning without the side effects associated with current weight loss drugs.

Key Takeaways

Researchers identify a naturally occurring gut bacterial metabolite that suppresses appetite and enhances fat metabolism
The postbiotic compound works through the gut-brain axis without the gastrointestinal side effects of current weight loss drugs
People maintaining healthy weight long-term had significantly higher circulating levels of this metabolite in a 5,000-person cohort

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

#weight-loss

GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment

The Next Shot: How GLP-1 Research Is Rewriting the Future of Weight Loss Medicine

NTU Scientists Develop Gut-Based Compound That Blocks Fat Absorption Safely

Natural Gut Compound Shows Promise for Safe Weight Loss

GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment

The Next Shot: How GLP-1 Research Is Rewriting the Future of Weight Loss Medicine

NTU Scientists Develop Gut-Based Compound That Blocks Fat Absorption Safely

Natural Gut Compound Shows Promise for Safe Weight Loss